Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Thorne Research and Helsinn Healthcare have launched the OncoQOL product line, which is a portfolio of 13 nutritional supplements to meet the nutritional needs of patients undergoing cancer treatment.
Subscribe to our email newsletter
The OncoQOL portfolio also includes theDermaQOL product line, with nine personal care products designed to support the skin-care and hair-care needs of cancer patients.
OncoQOL is a joint business effort between Helsinn and Thorne Research.
OncoQOL president Sreenivas Rao said for many cancer patients the side effects of treatment have a significant impact on their health and quality of life, often making it difficult for them to continue with their therapy.
”Our products are designed to meet the unique needs of these patients and are manufactured with the essential levels of purity and consistency that are so important for this population," Rao added.
The three nutritional supplements in the OncoQOL portfolio are DaxibeQOL ,utraQOL and MucosaQOL, while the DermaQOL portfolio personal care products include DermaQOL Lotio, DermaQOL Shower Gel and DermaQOL Cooling Aloe Spray.
Simms/Mann-UCLA Center for Integrative Oncology medical director Mary Hardy said, "In order to avoid negative interactions, cancer patients should choose products formulated with their needs in mind."